Daniel Dubé

Etoricoxib (MK-0663): Preclinical Profile and Comparison with Other Agents That Selectively Inhibit Cyclooxygenase-2

Denis Riendeau, M. David Percival, Christine Brideau et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 456 citations · Full text

Quinolines as potent 5-lipoxygenase inhibitors: Synthesis and biological profile of L-746,530

Daniel Dubé, Marc Blouin, Christine Brideau et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 271 citations · Full text

Medicinal Chemistry, Aldehyde Dehydrogenase, Biochemistry +10

2-Pyridinyl-3-(4-methylsulfonyl)phenylpyridines: Selective and orally active cyclooxygenase-2 inhibitors

Richard W. Friesen, Christine Brideau, Chi Chung Chan et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 128 citations · Full text

Medicinal Chemistry, Biochemistry, Active Cyclooxygenase-2 Inhibitors +9

Reductive N-alkylation of amides, carbamates and ureas

Daniel Dubé, Andrew A. Scholte · Tetrahedron Letters · 1999 · 114 citations

Engineering, Reductive N-alkylation, Organic Chemistry +2

Synthesis of (+)-avermectin B1a

Stephen Hanessian, Antonio Ugolini, Daniel Dubé et al. · Journal of the American Chemical Society · 1986 · 109 citations

-Avermectin B1a, Altmetrics, Bioorganic Chemistry +13